Previous patient-derived and experimental studies predominantly implicated immature cone precursors as the cellular origin of MYCN-amplified retinoblastomas [23], often reporting concurrent expression of photoreceptor markers (CRX, ARR3) and neuronal markers (synaptophysin) [27], indicative of dedifferentiated or partially differentiated states. The gene discussed is MYCN; the disease is retinoblastoma.